Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ALL, Adult and Pediatric”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07222202
What this trial is testing

Evaluation of Flexible Conductive Hearing Aids

Who this might be right for
Conductive Hearing Loss
Wake Forest University Health Sciences 200
Not applicableLooking for participantsNCT07786142
What this trial is testing

Transition of Care in Pediatric Rare Endocrine Disorders

Who this might be right for
Endocrine DisorderRare Disorders
Seoul National University Hospital 150
Large-scale testing (Phase 3)Looking for participantsNCT07605429
What this trial is testing

BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.

Who this might be right for
Angelman Syndrome
OHB Pediatrics Ltd. 165
Not applicableLooking for participantsNCT06084026
What this trial is testing

Measuring Physical Activity With ActivPal

Who this might be right for
Neuromuscular Diseases
Columbia University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04571138
What this trial is testing

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Seattle Children's Hospital 35
Testing effectiveness (Phase 2)Study completedNCT00055952
What this trial is testing

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

Who this might be right for
Sarcoma
Daiichi Sankyo
Early research (Phase 1)Ended earlyNCT00100152
What this trial is testing

A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)

Who this might be right for
Leukemia, Lymphoblastic, Acute, T-cellMyelogenous LeukemiaChronic Lymphocytic Leukemia+1 more
Merck Sharp & Dohme LLC 50
Large-scale testing (Phase 3)Study completedNCT01192022
What this trial is testing

TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery

Who this might be right for
Hemorrhage
Takeda 253
Testing effectiveness (Phase 2)Looking for participantsNCT00692939
What this trial is testing

Autologous Stem Cell Transplantation for Crohn's Disease

Who this might be right for
Crohn's Disease
Paul Szabolcs 20
Testing effectiveness (Phase 2)Study completedNCT00381940
What this trial is testing

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+17 more
National Cancer Institute (NCI) 26
Not applicableStudy completedNCT03703440
What this trial is testing

Group Education Trial to Improve Transition in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Type1diabetesInsulin Dependent Diabetes
McGill University Health Centre/Research Institute of the McGill University Health Centre 212
Early research (Phase 1)Active Not RecruitingNCT03500991
What this trial is testing

HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors

Who this might be right for
Central Nervous System Tumor, PediatricGliomaEpendymoma+6 more
Seattle Children's Hospital 10
Testing effectiveness (Phase 2)Study completedNCT01314300
What this trial is testing

Lidocaine 5% Plasters (Versatis® 5%) in Pediatric Neuropathic Pains and Vasoocclusive Sickle Cell Crisis Pains

Who this might be right for
Neuropathic PainsVasoocclusive Sickle Cell Crises Pains
Centre Leon Berard 39
Early research (Phase 1)Looking for participantsNCT07492316
What this trial is testing

RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB)

Who this might be right for
Recurrent Medulloblastoma
University of Florida 24
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Testing effectiveness (Phase 2)Study completedNCT04675931
What this trial is testing

To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria

Who this might be right for
Severe Malaria
Novartis Pharmaceuticals 254
Not applicableStudy completedNCT01445145
What this trial is testing

An Exploratory Study of the Use of Five Wishes as a Tool for Advanced Care Planning in Young Adults With Metastatic, Recurrent, or Progressive Cancer or HIV Infection

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 70
Not applicableLooking for participantsNCT03228875
What this trial is testing

Boston Birth Cohort Study

Who this might be right for
Maternal HealthChild HealthPregnancy Complications+1 more
Johns Hopkins Bloomberg School of Public Health 24,000
Early research (Phase 1)Study completedNCT03236857
What this trial is testing

The Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

Who this might be right for
MalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)+2 more
AbbVie 143
Post-approval studies (Phase 4)Study completedNCT00925730
What this trial is testing

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Who this might be right for
Atopic Dermatitis
Novartis 20
Next Page